RK Capital Management (Colorado)’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-170,084
Closed -$7.47M 29
2024
Q2
$7.47M Sell
170,084
-129,116
-43% -$5.49M 2% 23
2024
Q1
$13.2M Sell
299,200
-41,200
-12% -$1.82M 2.66% 19
2023
Q4
$16.2M Buy
340,400
+39,600
+13% +$1.66M 3.44% 7
2023
Q3
$13.3M Buy
300,800
+12,700
+4% +$590K 3.16% 12
2023
Q2
$13.8M Sell
288,100
-47,300
-14% -$2.13M 2.95% 14
2023
Q1
$13.2M Sell
335,400
-30,600
-8% -$1.11M 2.9% 12
2022
Q4
$10.4M Buy
366,000
+14,159
+4% +$405K 2.45% 15
2022
Q3
$10.6M Buy
351,841
+52,041
+17% +$1.81M 2.71% 13
2022
Q2
$10.2M Buy
299,800
+86,600
+41% +$3.1M 2.39% 17
2022
Q1
$9.56M Buy
213,200
+67,600
+46% +$3.13M 1.88% 19
2021
Q4
$6.73M Sell
145,600
-1,719
-1% -$69.3K 1.22% 41
2021
Q3
$4.95M Sell
147,319
-63,081
-30% -$2.15M 0.94% 53
2021
Q2
$6.19M Sell
210,400
-22,100
-10% -$609K 1.16% 49
2021
Q1
$5.99M Sell
232,500
-5,100
-2% -$122K 1.19% 43
2020
Q4
$5.42M Buy
237,600
+20,400
+9% +$471K 1.2% 43
2020
Q3
$4.64M Sell
217,200
-26,300
-11% -$591K 1.32% 36
2020
Q2
$5.65M Buy
243,500
+32,175
+15% +$691K 1.65% 25
2020
Q1
$4.51M Sell
211,325
-11,589
-5% -$276K 2.03% 19
2019
Q4
$5.21M Sell
222,914
-7,815
-3% -$183K 1.95% 23
2019
Q3
$4.85M Buy
230,729
+37,155
+19% +$758K 1.77% 27
2019
Q2
$3.96M Buy
193,574
+63,713
+49% +$1.5M 1.23% 38
2019
Q1
$3.65M Buy
+129,861
New +$3.4M 1.05% 37

Other funds holding IRMD

RK Capital Management (Colorado)'s IRMD Position: Q3 2024 in Review

RK Capital Management (Colorado) sold out of iRadimed (IRMD) in Q3 2024, closing a stake of 170,084 shares — an estimated $7.47M sold.

RK Capital Management (Colorado) first reported a position in IRMD in Q1 2019 and held it in 22 quarters. The position peaked at $16.2M in Q4 2023. 144 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.

  • RK Capital Management (Colorado) reported no remaining iRadimed position as of Q3 2024 after selling out during the quarter.
  • RK Capital Management (Colorado) sold 170,084 iRadimed shares in Q3 2024, an estimated $7.47M.
  • RK Capital Management (Colorado) first reported a position in iRadimed in Q1 2019 and held it in 22 quarters.
  • RK Capital Management (Colorado)'s iRadimed position peaked at $16.2M in Q4 2023.
  • 144 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.

Based on RK Capital Management (Colorado)'s 13F filing for Q3 2024, filed 13 Nov 2024.